ScienceLatest
Biotech VCs Face Disruption in Drug Development
Biotech venture capitalists are encountering challenges as traditional drug development methods are disrupted. This shift is forcing investors to adapt to new strategies in a rapidly evolving landscape.
0 upvotes
What happened
Biotech venture capitalists are encountering challenges as traditional drug development methods are disrupted.
Why it matters
This shift is forcing investors to adapt to new strategies in a rapidly evolving landscape.